The function of miR-199a-5p/Klotho regulating TLR4/NF-κB p65/NGAL pathways in rat mesangial cells cultured with high glucose and the mechanism

Molecular and Cellular Endocrinology

Volumn 417, Issue , 2015, Pages 84-93

  Wu, Can ^a   Lv, Chuan ^b   Chen, Fenqin ^a   Ma, Xiaoyu ^a   Shao, Ying ^a   Wang, Qiuyue ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Maternity and Child Healthcare Hospital of Liaoning Province   (China)

Author keywords

Anti aging protein Klotho; Diabetic kidney disease; MiR 199a 5p; Neutrophil gelatinase associated lipocalin; Toll like receptor 4

Indexed keywords

GLUCOSE; KLOTHO PROTEIN; MICRORNA; MICRORNA 199A 5P; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; BETA GLUCURONIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MIRN199 MICRORNA, RAT; TLR4 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; FIBROSIS; GENE EXPRESSION; IN VITRO STUDY; INFLAMMATION; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; GLUCOSE; GLUCURONIDASE; MESANGIAL CELLS; MICRORNAS; NF-KAPPA B; RATS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84960294522     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.09.024     Document Type: Article

References (33)

1. Berezikov E. Evolution of microRNA diversity and regulation in animals. Nat. Rev. Genet. 2011, 12(12):846-860.
2. Cheng M.F., Chen L.J., Cheng J.T. Decrease of Klotho in the kidney of streptozotocin-induced diabetic rats. J. Biomed. Biotechnol. 2010, 2010:513853.
3. Doi S., Zou Y., Toqao O., et al. Klotho inhibits transforming growth factor-β1 (TGF-β1) signaling and suppresses renal fibrosis and Cancer metastasis in mice. J. Biol. Chem. 2011, 286(10):8655-8665.
4. Fukao T., Fukuda Y., Kiga K., et al. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 2007, 129:617-631.
5. Glaros T., Fu Y., Xing J.H., et al. Molecular mechanism underlying persistent induction of LCN2 by lipopolysaccharide in kidney fibroblasts. Plos One 2012, 7(4):1-8.
6. Han M., Li Y., Liu M., et al. Renal neutrophil gelatinase associated lipocalin expression in lipopolysaccharide-induced acute kidney injury in the rat. BMC Nephrol. 2012, 13:25.
7. He Xu-Jun, Ma Ying-Yu, Yu Sheng, et al. Up-regulated miR-199a-5p in gastric cancer functions as an oncogene and targets klotho. MC Cancer 2014, 14:218.
8. Hu M.C., Shi M., Zhang J.N., et al. Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int. 2010, 78:1240-1251.
9. Huang Jau-Shyang, Chuang Chao-Tang, Liu Mei-Hsin, et al. Klotho attenuates high glucose-induced fibronectin and cell hypertrophy via the ERK1/2-p38 kinase signaling pathway in renal interstitial fibroblasts. Mol. Cell. Endocrinol. 2014, 390:45-53.
10. Kaur H., Chien A., Jiala I., et al. Hyperglycemia induced toll like receptor 4 expression and activity in Mouse Mesangia cells: relevance to diabetic ephropathy. Am. J. Physiol. Ren. Physiol. 2012, 303(8):F1145-F1150.
11. Kuro-o M., Matsumura Y., Aizawa H., et al. Mutation of the mouse Klotho gene leads to a syndrome resembling ageing. Nature 1997, 390(6655):45-51.
12. Kurosu H., Yamamoto M., Clark J.D., et al. Suppression of aging in mice by the hormone Klotho. Science 2005, 309(5742):1829-1833.
13. Le Z., Siyi H., Shaodong G., et al. Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1. J. Diabetes Complicat. 2014, 28(3):259-264.
14. Lee E.Y., Kim S.S., Lee J.-S., et al. Soluble a-klotho as a Novel biomarker in the early stage of nephropathy in patients with type 2 diabetes. PLoS ONE 2014, 9(8):e102984.
15. Li X., Du N., Zhang Q., et al. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis. 2014, 5(10):e1479.
16. Lin Y., Sun Z. Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes. Br. J. Pharmacol. 2011, 162(3):597-610.
17. Lin M., Yiu W.H., Wu H.J., et al. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J. Am. Soc. Nephrol. 2012, 23(1):86-102.
18. Lino Cardenas Christian Lacks, Henaoui Imène Sarah, Courcot Elisabeth, et al. miR-199a-5p is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting Caveolin-1. PLoS Genet. 2013, 9(2):e1003291.
19. Liu Guo-Dan, Zhang Hong, Wang Lin, et al. Molecular hydrogen regulates the expression of miR-9, miR-21 and miR-199 in LPS-activatedretinal microglia cells. Int. J. Ophthalmol. 2013, 6(3):280-285.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta DeltaC (T)) method. Methods 2001, 25(4):402-408.
21. Locke J.M., da SX G., Dawe H.R., et al. Increased expression of miR-187 in human islets from individuals with type 2 diabetes is associated with reduced glucose-stimulated insulin secretion. Diabetologia 2014, 57(1):122-128.
22. Lv C., Wu C., Zhou Y.H., Shao Y., Wang G., Wang Q.Y. Alpha lipoic acid modulated high glucose-induced rat mesangial cell dysfunction via mTOR/p70S6K/4E-BP1 pathway. Int. J. Endocrinol. 2014, 2014:658589.
23. Mungunsukh Ognoon, Day Regina M. Transforming growth factor-β1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199-dependent posttranscriptional mechanism. Mol. Biol. Cell 2013, 24(13):2088-2097.
24. Nunemaker C.S., Chung H.G., Verrilli G.M., et al. Increased serum CXCL1 and CXCL5 are linked to obesity, hyperglycemia, and impaired islet function. J. Endocrinol. 2014, 222(2):267-276.
25. Suchankova G., Nelson L.E., Gerhart-Hines Z., Kelly M., Gauthier M.S., Saha A.K., Ido Y., Puigserver P., Ruderman N.B. Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem. Biophys. Res. Commun. 2009, 378:836-841.
26. Tarabra E., Giunti S., Barutta F., et al. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes. Diabetes 2009, 58(9):2109-2118.
27. Tsukigi M., Bilim V., Yuuki K., Ugolkov A., Naito S., Nagaoka A., Kato T., Motoyama T., Tomita Y. Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3beta. Cancer Lett. 2012, 315:189-197.
28. Wang J., He Q., Han C., et al. p53-facilitated miR-199a-3p regulates somatic cell reprogramming. Stem Cells 2012, 30:1405-1413.
29. Wu C., Wang Q.Y., Lv C., et al. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin. Diabetes Res. Clin. Pract. 2014, 106(2):343-350.
30. Yamazaki Y., Imura A., Urakawa I., et al. Establishment of sandwich ELISA for soluble alpha-Klotho measurement: age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem. Biophys. Res. Commun. 2010, 398(3):513-518.
31. Zang M., Zuccollo A., Hou X., Nagata D., Walsh K., Herscovitz H., Brecher P., Ruderman N.B., Cohen R.A. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J. Biol. Chem. 2004, 279:47898-47905.
32. Zhao Y., Banerjee S., Dey N., et al. Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation. Diabetes 2011, 60(7):1907-1916.
33. Ziyadeh E.F. The extracellular matrix in diabetic nephropathy. Am. J. Kidney Dis. 1993, 22:736-744.